No need for concern. Filing the patent effectively secures the IP in examination until the normal back-and-forth process of review is concluded and the outcome shared. Given the data and process of testing against other cancer indications (100+), as well as the supporting body of evidence to date (and more cardio data to come), there should be no issue with this patent being granted eventually.
General Comments / Chat, page-7702
-
- There are more pages in this discussion • 3,854 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
